Our Leaders
Meet the Team That's Revolutionizing Disease Interception
Jeremy Stueven, MD, MBA
CHIEF EXECUTIVE OFFICER
- Board Certified in Emergency Medicine
- 15 years of real-life clinical experience
- Patient-centric, results-driven entrepreneur
- Transformative healthcare leader
Jeff Wigdahl, PhD
CHIEF TECHNOLOGY OFFICER
- PhD from the University of Padua
- Strong background in image processing, machine learning, and vision-related research
- Developed retinal vascular measurement software
- NIH SBIR award winner
Nate Wyatt
CHIEF INFORMATION OFFICER
- DevOps Expert
- Software engineer
- Formerly with Netskope & Microsoft
- Extensive Software Development
Darwin Harrison, MAcc
CHIEF FINANCIAL OFFICER/CHIEF OPERATING OFFICER
- 30 years experience in healthcare finance
- 30 years experience in execution of healthcare organizations
- Extensive start-up experience
- Expert in accounting & finance
Davin Isakson
CHIEF SALES OFFICER
- MBA from the University of Notre Dame
- 20 years of experience driving revenue growth and client success
- 20 years in the medical device and healthcare technology sectors
Our Advisors
John Pitcher, MD
TRIAL/RETINAL ADVISOR
Vlad Matei, MD
RETINAL/MEDICAL ADVISOR
Darlene Harbour, BSN
CLINICAL RESEARCH
Kevin Walls
FDA EXPERT ADVISOR
Waneta Tuttle, PhD
TRAMWAY VENTURE PARTNERS
KickStart Fund
INVESTMENT ADVISOR
Brad Vale
TREO VENTURE PARTNERS
Lerner Venture Law
LEGAL ADVISOR
Sheppard & Mullin
HEALTHCARE/TELEHEALTH LAW
How Vitazi.ai Can Help
Technology has the potential to improve access to systemic health screening, reducing the progression of the disease for many and improving lives. If a screening could be done in minutes as part of a regular checkup, access to vital screening is solved. Going further, this could enable establishment of entirely new, systemic screening programs for several diseases within the space of Oculomics.
